Alveolus

Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.

Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.

Number of Funding Rounds

Total Funding Amount

1

$10M

Alveolus has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Jul 30, 2004 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 30, 2004	Series B	$10M	2	—	—	Detail

Number of Lead Investors

Number of Investors

—

2

Alveolus is funded by 2 investors. EGS Healthcare Capital Partners and Matignon Technologies are the most recent investors.

Investor Name	Lead Investor	Funding Round
EGS Healthcare Capital Partners	—	Series B
Matignon Technologies	—	Series B